Halbert Hargrove Global Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Halbert Hargrove Global Advisors's PFE Position: Q2 2026 in Review
Halbert Hargrove Global Advisors opened a new position in Pfizer (PFE) in Q2 2026: 17 shares worth $420. The stake represents ﹤0.01% of the portfolio and ranks #558 among its holdings. This is a return to the name: Halbert Hargrove Global Advisors previously reported a position in PFE as recently as Q3 2025.
Halbert Hargrove Global Advisors first reported a position in PFE in Q2 2013 and has held it in 41 quarters since. The position peaked at $1.06M in Q4 2021. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Halbert Hargrove Global Advisors held 17 shares of Pfizer worth $420 as of Q2 2026.
- Pfizer was a new Halbert Hargrove Global Advisors position in Q2 2026.
- Pfizer made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #558 holding.
- Halbert Hargrove Global Advisors first reported a position in Pfizer in Q2 2013 and has held it in 41 quarters since.
- Halbert Hargrove Global Advisors's Pfizer position peaked at $1.06M in Q4 2021.
- 1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.